Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
- BIOLOGICAL: bevacizumab
- GENETIC: gene expression analysis
- GENETIC: protein expression analysis
- OTHER: laboratory biomarker analysis
Sponsor
Mayo Clinic
Collaborators